{
    "eid": "2-s2.0-85111609555",
    "title": "Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery \u2013 A review",
    "cover-date": "2021-09-05",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Carbonic anhydrase inhibitor",
        "Cyclodextrin",
        "Glaucoma",
        "Intraocular pressure",
        "Nanocarrier",
        "Solubilization"
    ],
    "authors": [
        "Phatsawee Jansook",
        "Hay Marn Hnin",
        "Thorsteinn Loftsson",
        "Einar Stef\u00e1nsson"
    ],
    "citedby-count": 12,
    "ref-count": 116,
    "ref-list": [
        "Medical management of glaucoma",
        "Cyclodextrins in acetazolamide eye drop formulations",
        "Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride",
        "Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery",
        "Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report",
        "Permeability of the cornea to topically applied drugs",
        "Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the US Preventive Services Task Force",
        "Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups",
        "Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents",
        "pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors",
        "Cross-linked hyaluronan films loaded with acetazolamide\u2013cyclodextrin\u2013triethanolamine complexes for glaucoma treatment",
        "Novel therapies for glaucoma: a patent review 2007\u20132011",
        "Methazolamide calcium phosphate nanoparticles in an ocular delivery system",
        "Lacrimal and instilled fluid dynamics in rabbit eyes",
        "Current medical therapy and future trends in the management of glaucoma treatment",
        "Preclinical overview of brinzolamide",
        "Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors",
        "Preparation and evaluation of acetazolamide liposomes as an ocular delivery system",
        "Exploring optimized methoxy poly(ethylene glycol)-block-poly(\u03b5-caprolactone) crystalline cored micelles in anti-glaucoma pharmacotherapy",
        "Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%",
        "Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits",
        "Formulation and testing of methazolamide cyclodextrin eye drop solutions",
        "The prevalence of open-angle glaucoma among blacks and whites 73 years and older: the Salisbury Eye Evaluation Glaucoma Study",
        "Structure-activity relationship of human carbonic anhydrase-II inhibitors: Detailed insight for future development as anti-glaucoma agents",
        "Promising complexes of acetazolamide for topical ocular administration",
        "Synthesis, characterization and in vitro release studies of a new acetazolamide\u2013HP-\u03b2-CD\u2013TEA inclusion complex",
        "\u03b3-Cyclodextrin nanoparticle eye drops with dorzolamide: effect on intraocular pressure in man",
        "Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide",
        "Brinzolamide",
        "Medical management of glaucoma in the 21st century from a Canadian perspective",
        "Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies",
        "Brinzolamide",
        "Creation of nano eye-drops and effective drug delivery to the interior of the eye",
        "Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: Formulation of dorzolamide eye drop microparticle suspension",
        "Increase in aqueous solubility, stability and in vitro corneal permeability of anandamide by hydroxypropyl-\u03b2-cyclodextrin",
        "TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma",
        "Formulation and evaluation of ophthalmic preparations of acetazolamide",
        "Acetazolamide: future perspective in topical glaucoma therapeutics",
        "Glaucoma is second leading cause of blindness globally",
        "Irreversible corneal decompensation in patients treated with topical dorzolamide",
        "Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients",
        "Corneal penetration behavior of \u03b2-blocking agents II: assessment of barrier contributions",
        "Biological barriers to ocular delivery",
        "Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits",
        "A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide",
        "The effect of polyethylene glycol molecular weight on corneal transport and the related influence of penetration enhancers",
        "The effect of drug charge type and charge density on corneal transport",
        "Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy",
        "Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization",
        "Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits",
        "Evaluation of cyclodextrin solubilization of drugs",
        "Effect of cyclodextrins on topical drug delivery to the eye",
        "Cyclodextrins in ophthalmic drug delivery",
        "Fabrication and characterization of mucoadhesive topical nanoformulations of dorzolamide HCl for ocular hypertension",
        "Antiglaucoma carbonic anhydrase inhibitors: a patent review",
        "Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans",
        "Self-assembled cyclodextrin aggregates and nanoparticles",
        "The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents",
        "Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits",
        "Characterization, dissolution and in vivo evaluation of solid acetazolamide complexes",
        "Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide",
        "Aqueous humor pharmacokinetics of dorzolamide loaded PLGAChitosan nanoparticles by ultra performance liquid chromatography",
        "Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension",
        "An efficient ternary complex of acetazolamide with HP-ss-CD and TEA for topical ocular administration",
        "Chitosan nanoparticles loaded with dorzolamide and pramipexole",
        "Acetazolamide",
        "Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes",
        "Dorzolamide, a 40-year wait. From an oral to a topical carbonic anhydrase inhibitor for the treatment of glaucoma",
        "Glaucoma",
        "Novel polymeric nanoparticles intended for ophthalmic administration of acetazolamide",
        "Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy",
        "Hydrophilic acrylic hydrogels with built-in or pendant cyclodextrins for delivery of anti-glaucoma drugs",
        "Penetration of \u03b2-blockers through ocular membranes in albino rabbits",
        "Carbonic anhydrase inhibitors. synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: Is the tail more important than the ring?",
        "Carbonic anhydrase inhibitors: perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action",
        "Glaucoma and the applications of carbonic anhydrase inhibitors",
        "Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments",
        "Development of dorzolamide loaded 6-o-carboxymethyl chitosan nanoparticles for open angle glaucoma",
        "Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration",
        "Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study",
        "Intraocular pressure and glaucoma",
        "Topical drug delivery to the posterior segment of the eye: Thermodynamic considerations",
        "Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors",
        "Carbonic anhydrases: novel therapeutic applications for inhibitors and activators",
        "Carbonic anhydrase inhibitors and their therapeutic potential",
        "Carbonic anhydrase inhibitors",
        "Introduction and general overview of cyclodextrin chemistry",
        "Improvement of acetazolamide ocular permeation using ascorbyl laurate nanostructures as drug delivery system",
        "Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis",
        "Delivery of antiglaucoma drugs: ocular vs systemic absorption",
        "Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide",
        "Preparation, optimization, and characterization of chitosan-coated solid lipid nanoparticles for ocular drug delivery",
        "Nanoliposome-encapsulated brinzolamide-hydropropyl-\u03b2-cyclodextrin inclusion complex: A potential therapeutic ocular drug-delivery system",
        "Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study",
        "Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: A comparison with corneal penetration",
        "Comparison of conjunctival and corneal surface areas in rabbit and human",
        "PVA hydrogels containing beta-cyclodextrin for enhanced loading and sustained release of ocular therapeutics",
        "Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide",
        "Development of inclusion complex of brinzolamide with hydroxypropyl-\u03b2-cyclodextrin",
        "Core-shell lipid-polymer nanoparticles as a promising ocular drug delivery system to treat glaucoma"
    ],
    "affiliation": [
        {
            "affiliation-city": "Reykjavik",
            "@id": "60071115",
            "affilname": "L\u00e6knadeild H\u00e1sk\u00f3la \u00cdslands",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071115",
            "affiliation-country": "Iceland"
        },
        {
            "affiliation-city": "Reykjavik",
            "@id": "60071113",
            "affilname": "Haskoli Islands",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071113",
            "affiliation-country": "Iceland"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}